Facing the Future of Neuromodulation

May 17, 2019 by NTS Conference in  NTS News

With: Roy Hamilton, MD

We spoke with Dr. Roy Hamilton, Associate Professor in the departments of Neurology and Physical Medicine and Rehabilitation at the University of Pennsylvania, where he also directs the Laboratory for Cognition and Neural Stimulation (LCNS). Dr. Hamilton has been engaged in research in the field of brain stimulation since 1998, and has employed transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tDCS) in a range of studies exploring a variety of topics including cognitive control, visuospatial processing, language production, semantic memory, and creativity.

NTS/NYN: Can you describe the more formative experiences in his education or training that informed his current research?

My career in neuromodulation has focused on employing noninvasive brain stimulation techniques such as TMS and tDCS as tools for the elucidating systems-level neuroscientific principles that give rise to human cognition, and to employ the same tools to enhance the recovery of patients with focal deficits of cognition resulting from brain insults such as stroke and neurodegenerative disease.

In terms of specific technologies, ideas, or applications that inspired me, my formative years were spent at the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, where I developed a passion for neuromodulation by working with Alvaro Pascual-Leone, MD, PhD. Dr. Pascual-Leone is considered a pioneer in the field of noninvasive brain stimulation. In subsequent years, I had the opportunity to grow as a behavioral neurologist by working with another luminary in this field, H. Branch Coslett, MD at the University of Pennsylvania.

I’ve enjoyed approximately 20 years in the field of noninvasive brain stimulation, and I eagerly look forward to the discoveries and challenges that the future holds for this field.

NTS/NYN: What excites you about this year’s Joint Meeting of Neuromodulation: The Science and NYC Neuromodulation?

In recent years I have witnessed remarkable advances in the ability of neuroscience to characterize and influence brain circuits that drive sensorimotor functions, cognition, and behavior. Neuromodulation techniques have emerged as especially powerful tools, both for interrogating intact brain centers experimentally and for promoting recovery in patients with neurologic deficits, cognitive impairments, and psychiatric symptoms. I am most excited that neuromodulation approaches are increasingly being combined synergistically with other cutting-edge advances in neuroscience in order to make increasingly sophisticated inferences about the structure/function relationships that underlie cognition, perception, and action, the mechanisms by which neurologic and psychiatric disorders negatively impact these processes, and the ways in which novel neuromodulation-based interventions may be effective in treating these conditions.

I am looking forward to this opportunity for both eminent thought leaders and rising stars in the field of neuromodulation to share their groundbreaking insights at NTS/NYN 2019. These insights are supported by the most robust scientific evidence available.

 

Neuromodulation: The Science & NYC Neuromodulation sessions will include topics on neural engineering, deep brain stimulation, spinal cord stimulation, closed loop brain machine interfacing, bioelectronic medicine, non-invasive brain stimulation, and non-invasive stimulation of organ systems. Please take a moment to view the complete scientific agenda. NTS/NYN will be held in Napa, CA on October 3–6, 2019.

Register today.

Neuromodulation: the Science
an Origin Story

May 02, 2019

By: Dr. Elliot Krames
Founding Editor-in-Chief, Neuromodulation: Technology at the Neural Interface; Past President, International Neuromodulation Society (INS)

Elliot S. Krames, MD
Conference Director

Learning to Speak the Language of Nerves

May 21, 2019

With: Christopher J. Czura, PhD

This October in Napa, Neuromodulation: The Science and NYC Neuromodulation (NTS/NYN) will bring together the new and exciting pre-clinical and clinical sciences of invasive and non-invasive neuromodulation.  NTS/NYN has gathered an impressive faculty that includes well-known scientists and engineers from around the world.

Groundbreaking Partnership Gathers Top Neuroscientists, Clinicians, and Neuroengineers to Napa Valley

May 23, 2019

Joint conference addresses cutting-edge science and technology for patient care including treatment of pain, disease, neurological and psychiatric disorders

 

May 30, 2019  Napa, Ca – The emerging science of neuromodulation is poised to transform the treatment of neurological and psychiatric disorders, including chronic pain. This Fall, Neuromodulation: The Science and NYC Neuromodulation partners to host leaders in neuroscience focusing on the scientific discoveries that are transforming neuromodulation technologies.

This event brings together two of the largest conferences established to advance research and disseminate knowledge and implementation of new findings, including optimized approaches for diseases such as chronic headache, spasticity, chronic pain, epilepsy, and paralysis.

The conference takes place during the harvest season in Napa Valley, commonly known as “the Crush”. Attendees will have the opportunity for wine tastings and access to local wineries. Grigsby, a Napa Valley physician, and a vineyard owner, founded Neurovations over 26 years ago and is at the forefront of pain care nationwide.

“This event brings together the top minds in science and technology. At the end of the day, we always want what is best for patients in pain, those suffering neurologic psychiatric diseases, and in neurorehabilitation” said Dr. Grigsby. “Dr. Bikson, one of the nation’s top biomedical engineers, will highlight the absolute cutting edge of brain interface technology including closed-loop neuromodulation for patient-specific interventions,” continued Grigsby.

Neuromodulation, as noted by leading expert Dr. Elliot Krames, is defined as the field of science, medicine, and bioengineering that encompasses implantable and non-implantable technologies, electrical or chemical, for the purpose of improving quality of life and functioning of humans. “This partnership allows us to dive deeply into pure science that could allow us to treat pain, psychiatric disorders, movement disorders, and other diseases in less invasive and non-destructive ways. This is truly the future of medicine,” said Krames.

Prof. Bikson, founding chairman of Neuromodec, studies the effects of electricity on the human body and applies this knowledge toward the development of medical devices.

“Something very special will happen this October. For the first time Neuromodulation: The Science, the conference at the forefront of the science of therapeutic brain interfaces, and NYC Neuromodulation, the conference where new brain stimulation technologies are presented, will coordinate a joint meeting. There is a shared principle that new science drives the creation of better therapies. And there is something poetic about this happening literally in the midst of the grape harvest in Napa,” said Bikson.

Don’t miss the Joint Meeting of Neuromodulation: The Science & NYC Neuromodulation, Oct 3-6, 2019. Register today.

View the agenda: Here.